17.22USD+0.23%Mkt Cap: 400.18M USDP/E: —Last update: 2026-06-01
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap400.18M USD
Enterprise Value199.21M USD
Revenue (TTM)31.00K USD
Gross Profit31.00K USD
Net Income (TTM)-274.45M USD
Revenue/Share0.0020 USD
Last Price17.22 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-20.63
PEG—
EV/EBITDA-1.13
EV/Revenue6426.06
P/S13044.51
P/B1.48
EPS (TTM)-13.62
EPS (Forward)-0.84
52W Range
7.65026% of range45.00
52W High45.00 USD
52W Low7.650 USD
Profitability
Gross Margin100.00%
Oper. Margin-2213050.00%
EBITDA Margin0.00%
Profit Margin-762355.56%
ROE-110.57%
ROA-80.71%
Growth
Revenue Growth-71.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-150.02M USD
CapEx (TTM)780.00K USD
FCF Margin-249615.33%
FCF Yield-19.34%
Net Debt-205.17M USD
Net Debt/EBITDA1.17
Balance Sheet
Debt/Equity0.21
Current Ratio7.24
Quick Ratio6.88
Book Value/Sh11.73 USD
Cash/Share10.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 2, 2025
Analyst Consensus
Rating—
Target (Mean)37.17 USD
Target Range12.00 USD – 49.00 USD
# Analysts6
Ownership
Shares Out.23.33M
Float10.39M
Insiders35.44%
Institutions58.33%
Short Interest
Short Ratio20.2d
Short % Float6.76%
Short % Out.5.74%
Shares Short1.34M
Short (prev mo.)1.23M
Technical
SMA 5020.57 (-16.3%)
SMA 20020.57 (-16.3%)
Beta-0.06
S&P 52W Chg27.94%
Avg Vol (30d)65.62K
Avg Vol (10d)84.19K
Technical Indicators
RSI (14)38.3
MACD-1.2864
MACD Signal-1.2581
MACD Hist.-0.0283
BB Upper21.74 USD
BB Middle18.44 USD
BB Lower15.14 USD
BB Width35.78%
ATR (14)1.300 USD
Vol Ratio (20d)0.65x